Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-03-17

AUTHORS

Hye Sung Kim, Jae Hyuck Choi, Jae Young Lee, JiHoon Kang, Jae Kyung Myung, Woo Ho Kim, Bo Gun Jang

ABSTRACT

Secreted Protein Acidic and Rich in Cysteine (SPARC)-related modular calcium-binding protein-2 (SMOC2), a secreted matricellular protein, is reported to be involved in various processes related to cancer progression such as regulating the cell cycle, angiogenesis, and invasion. However, its expression and prognostic significance in papillary thyroid carcinomas (PTCs) remains unknown. Using immunohistochemistry, we evaluated the expression profile of SMOC2 and its prognostic value in a large cohort of PTCs. Real time-PCR analysis with fresh-frozen tissues showed that SMOC2 mRNA expression in PTCs was substantially lower than the expression in matched non-cancerous thyroid tissues, consistent with the results from thyroid cancer cell lines. Immunohistochemical analysis demonstrated that SMOC2 was normally present in thyroid follicular epithelial cells and the expression level was maintained in nodular hyperplasia. However, SMOC2 expression was significantly lower in lymphocytic thyroiditis and follicular tumors including follicular adenomas and carcinomas. In particular, 38% of PTCs exhibited a complete loss of SMOC2 expression, which was associated with the presence of BRAF (V600E) mutation. Moreover, SMOC2 further declined during lymph node metastasis in PTCs. DNA methylation chip analysis revealed one hypermethylated CpG site in the promoter region of SMOC2 gene, suggesting an epigenetic regulation of SMOC2 in PTCs. Remarkably SMOC2 positivity was associated with improved recurrence-free survival along with female sex, tumor size, and the N stage. However, SMOC2 was not identified as an independent prognostic marker in multivariate analyses. Taken together, SMOC2 expression is significantly down-regulated in PTCs and SMOC2 positivity is closely associated with better clinical outcomes, suggesting that SMOC2 can be a prognostic marker in PTC patients. More... »

PAGES

4853

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-020-61828-z

DOI

http://dx.doi.org/10.1038/s41598-020-61828-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1125689024

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32184420


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Substitution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Methylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epigenesis, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins B-raf", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sex Characteristics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Cancer, Papillary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Burden", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.411277.6", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Hye Sung", 
        "id": "sg:person.0771453563.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771453563.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.411277.6", 
          "name": [
            "Department of Surgery, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Choi", 
        "givenName": "Jae Hyuck", 
        "id": "sg:person.0651672565.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651672565.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.411277.6", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Jae Young", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, South Korea Institute of Radiological & Medical Sciences, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.415464.6", 
          "name": [
            "Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, South Korea Institute of Radiological & Medical Sciences, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "JiHoon", 
        "id": "sg:person.0703331164.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703331164.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Korea Cancer Center Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.415464.6", 
          "name": [
            "Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, South Korea Institute of Radiological & Medical Sciences, Seoul, South Korea", 
            "Department of Pathology, Korea Cancer Center Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Myung", 
        "givenName": "Jae Kyung", 
        "id": "sg:person.0701520567.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701520567.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Woo Ho", 
        "id": "sg:person.016630576674.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016630576674.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.411277.6", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jang", 
        "givenName": "Bo Gun", 
        "id": "sg:person.0640426775.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640426775.09"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrg3230", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028633739", 
          "https://doi.org/10.1038/nrg3230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2015.127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016735278", 
          "https://doi.org/10.1038/onc.2015.127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00401-011-0841-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020149937", 
          "https://doi.org/10.1007/s00401-011-0841-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrendo.2011.142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021894967", 
          "https://doi.org/10.1038/nrendo.2011.142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-013-9908-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019492954", 
          "https://doi.org/10.1007/s12020-013-9908-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-03-17", 
    "datePublishedReg": "2020-03-17", 
    "description": "Secreted Protein Acidic and Rich in Cysteine (SPARC)-related modular calcium-binding protein-2 (SMOC2), a secreted matricellular protein, is reported to be involved in various processes related to cancer progression such as regulating the cell cycle, angiogenesis, and invasion. However, its expression and prognostic significance in papillary thyroid carcinomas (PTCs) remains unknown. Using immunohistochemistry, we evaluated the expression profile of SMOC2 and its prognostic value in a large cohort of PTCs. Real time-PCR analysis with fresh-frozen tissues showed that SMOC2 mRNA expression in PTCs was substantially lower than the expression in matched non-cancerous thyroid tissues, consistent with the results from thyroid cancer cell lines. Immunohistochemical analysis demonstrated that SMOC2 was normally present in thyroid follicular epithelial cells and the expression level was maintained in nodular hyperplasia. However, SMOC2 expression was significantly lower in lymphocytic thyroiditis and follicular tumors including follicular adenomas and carcinomas. In particular, 38% of PTCs exhibited a complete loss of SMOC2 expression, which was associated with the presence of BRAF (V600E) mutation. Moreover, SMOC2 further declined during lymph node metastasis in PTCs. DNA methylation chip analysis revealed one hypermethylated CpG site in the promoter region of SMOC2 gene, suggesting an epigenetic regulation of SMOC2 in PTCs. Remarkably SMOC2 positivity was associated with improved recurrence-free survival along with female sex, tumor size, and the N stage. However, SMOC2 was not identified as an independent prognostic marker in multivariate analyses. Taken together, SMOC2 expression is significantly down-regulated in PTCs and SMOC2 positivity is closely associated with better clinical outcomes, suggesting that SMOC2 can be a prognostic marker in PTC patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-020-61828-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "SMOC2 expression", 
      "real-time PCR analysis", 
      "time PCR analysis", 
      "non-cancerous thyroid tissues", 
      "epigenetic regulation", 
      "thyroid cancer cell lines", 
      "Secreted Protein Acidic", 
      "promoter region", 
      "expression profiles", 
      "cell cycle", 
      "chip analysis", 
      "thyroid follicular epithelial cells", 
      "CpG sites", 
      "SMOC2", 
      "matricellular protein", 
      "protein 2", 
      "cancer progression", 
      "cancer cell lines", 
      "follicular epithelial cells", 
      "Protein Acidic", 
      "SMOC2 gene", 
      "expression levels", 
      "cell lines", 
      "complete loss", 
      "modular calcium-binding protein 2", 
      "epithelial cells", 
      "expression", 
      "papillary thyroid carcinoma", 
      "mRNA expression", 
      "genes", 
      "protein", 
      "mutations", 
      "markers", 
      "fresh frozen tissue", 
      "tissue", 
      "cysteine", 
      "regulation", 
      "downregulation", 
      "prognostic marker", 
      "immunohistochemical analysis", 
      "invasion", 
      "cells", 
      "angiogenesis", 
      "thyroid tissue", 
      "BRAF mutations", 
      "thyroid carcinoma", 
      "sites", 
      "analysis", 
      "acidic", 
      "lines", 
      "progression", 
      "survival", 
      "region", 
      "significance", 
      "cycle", 
      "PTC patients", 
      "stage", 
      "independent prognostic marker", 
      "follicular adenoma", 
      "follicular tumors", 
      "loss", 
      "presence", 
      "metastasis", 
      "levels", 
      "immunohistochemistry", 
      "profile", 
      "carcinoma", 
      "size", 
      "lymph node metastasis", 
      "Rich", 
      "process", 
      "tumors", 
      "prognostic significance", 
      "node metastasis", 
      "improved recurrence-free survival", 
      "sex", 
      "large cohort", 
      "recurrence-free survival", 
      "results", 
      "better clinical outcomes", 
      "prognostic value", 
      "lymphocytic thyroiditis", 
      "tumor size", 
      "clinical outcomes", 
      "nodular hyperplasia", 
      "female sex", 
      "multivariate analysis", 
      "adenomas", 
      "hyperplasia", 
      "positivity", 
      "thyroiditis", 
      "patients", 
      "cohort", 
      "values", 
      "outcomes", 
      "calcium-binding protein-2", 
      "SMOC2 mRNA expression", 
      "DNA methylation chip analysis", 
      "methylation chip analysis", 
      "SMOC2 positivity"
    ], 
    "name": "Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance", 
    "pagination": "4853", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1125689024"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-020-61828-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32184420"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-020-61828-z", 
      "https://app.dimensions.ai/details/publication/pub.1125689024"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_870.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-020-61828-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-61828-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-61828-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-61828-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-61828-z'


 

This table displays all metadata directly associated to this object as RDF triples.

316 TRIPLES      22 PREDICATES      152 URIs      137 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-020-61828-z schema:about N10f0e59c69444c92a9296dc06acd8836
2 N18e2871013ef4da4a7bf85dc830dfacc
3 N18f67b73fab345d18588f479ecbd806a
4 N2403f3ad3b6443a8ab62f7ccfba75311
5 N34221dfd1fd04e97bba432552583fad3
6 N37304afdd92b4379a72eaf0692885bb7
7 N4984f15d372347318b20716186bbc9af
8 N5e4f2f67bb01482eb81464128fe08e51
9 N6b6b2b842b224089a045b785e5d0fe13
10 N747f712158f148149ce7ad3d62de5a23
11 N7e47cc8326ea445b9ee59b041e695bde
12 N8c3abb0a99e24b918106f27f660eabb0
13 N959745a3a9e34459a2e5043398655a30
14 Nb222fd60b1ba4139828f28ffac3cdcad
15 Nb5360373e96c4a44977076daab44cbf8
16 Nba2d66f3a9744bfb83470cedb7b9f539
17 Nc5aee7d7bade4d81909d0b391fc72c74
18 Nd4ff6e1251ac41eda43f000b179ceeeb
19 Neb434e036ff04efe8cdd55703130dec6
20 anzsrc-for:06
21 anzsrc-for:0604
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N441f7c05f9b5425abfed28f0c548e689
25 schema:citation sg:pub.10.1007/s00401-011-0841-z
26 sg:pub.10.1007/s12020-013-9908-z
27 sg:pub.10.1038/nrendo.2011.142
28 sg:pub.10.1038/nrg3230
29 sg:pub.10.1038/onc.2015.127
30 schema:datePublished 2020-03-17
31 schema:datePublishedReg 2020-03-17
32 schema:description Secreted Protein Acidic and Rich in Cysteine (SPARC)-related modular calcium-binding protein-2 (SMOC2), a secreted matricellular protein, is reported to be involved in various processes related to cancer progression such as regulating the cell cycle, angiogenesis, and invasion. However, its expression and prognostic significance in papillary thyroid carcinomas (PTCs) remains unknown. Using immunohistochemistry, we evaluated the expression profile of SMOC2 and its prognostic value in a large cohort of PTCs. Real time-PCR analysis with fresh-frozen tissues showed that SMOC2 mRNA expression in PTCs was substantially lower than the expression in matched non-cancerous thyroid tissues, consistent with the results from thyroid cancer cell lines. Immunohistochemical analysis demonstrated that SMOC2 was normally present in thyroid follicular epithelial cells and the expression level was maintained in nodular hyperplasia. However, SMOC2 expression was significantly lower in lymphocytic thyroiditis and follicular tumors including follicular adenomas and carcinomas. In particular, 38% of PTCs exhibited a complete loss of SMOC2 expression, which was associated with the presence of BRAF (V600E) mutation. Moreover, SMOC2 further declined during lymph node metastasis in PTCs. DNA methylation chip analysis revealed one hypermethylated CpG site in the promoter region of SMOC2 gene, suggesting an epigenetic regulation of SMOC2 in PTCs. Remarkably SMOC2 positivity was associated with improved recurrence-free survival along with female sex, tumor size, and the N stage. However, SMOC2 was not identified as an independent prognostic marker in multivariate analyses. Taken together, SMOC2 expression is significantly down-regulated in PTCs and SMOC2 positivity is closely associated with better clinical outcomes, suggesting that SMOC2 can be a prognostic marker in PTC patients.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree true
36 schema:isPartOf N8f04d35fec414fcd9e9948f221778804
37 N93a27a53bd1d45ff911e38bdb07ebaaf
38 sg:journal.1045337
39 schema:keywords BRAF mutations
40 CpG sites
41 DNA methylation chip analysis
42 PTC patients
43 Protein Acidic
44 Rich
45 SMOC2
46 SMOC2 expression
47 SMOC2 gene
48 SMOC2 mRNA expression
49 SMOC2 positivity
50 Secreted Protein Acidic
51 acidic
52 adenomas
53 analysis
54 angiogenesis
55 better clinical outcomes
56 calcium-binding protein-2
57 cancer cell lines
58 cancer progression
59 carcinoma
60 cell cycle
61 cell lines
62 cells
63 chip analysis
64 clinical outcomes
65 cohort
66 complete loss
67 cycle
68 cysteine
69 downregulation
70 epigenetic regulation
71 epithelial cells
72 expression
73 expression levels
74 expression profiles
75 female sex
76 follicular adenoma
77 follicular epithelial cells
78 follicular tumors
79 fresh frozen tissue
80 genes
81 hyperplasia
82 immunohistochemical analysis
83 immunohistochemistry
84 improved recurrence-free survival
85 independent prognostic marker
86 invasion
87 large cohort
88 levels
89 lines
90 loss
91 lymph node metastasis
92 lymphocytic thyroiditis
93 mRNA expression
94 markers
95 matricellular protein
96 metastasis
97 methylation chip analysis
98 modular calcium-binding protein 2
99 multivariate analysis
100 mutations
101 node metastasis
102 nodular hyperplasia
103 non-cancerous thyroid tissues
104 outcomes
105 papillary thyroid carcinoma
106 patients
107 positivity
108 presence
109 process
110 profile
111 prognostic marker
112 prognostic significance
113 prognostic value
114 progression
115 promoter region
116 protein
117 protein 2
118 real-time PCR analysis
119 recurrence-free survival
120 region
121 regulation
122 results
123 sex
124 significance
125 sites
126 size
127 stage
128 survival
129 thyroid cancer cell lines
130 thyroid carcinoma
131 thyroid follicular epithelial cells
132 thyroid tissue
133 thyroiditis
134 time PCR analysis
135 tissue
136 tumor size
137 tumors
138 values
139 schema:name Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance
140 schema:pagination 4853
141 schema:productId N471555c8f5424f1a85f236ec5d6c5042
142 Nbecc7f4311874fd5978a6188fb821f9f
143 Ndb88d75880904e849476f16c84345e41
144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1125689024
145 https://doi.org/10.1038/s41598-020-61828-z
146 schema:sdDatePublished 2022-01-01T19:00
147 schema:sdLicense https://scigraph.springernature.com/explorer/license/
148 schema:sdPublisher N8b72477031714d01986a207a31464d7d
149 schema:url https://doi.org/10.1038/s41598-020-61828-z
150 sgo:license sg:explorer/license/
151 sgo:sdDataset articles
152 rdf:type schema:ScholarlyArticle
153 N0515bae5a6e84b08a45c67a788087b11 rdf:first N20f359f588884b169dafcb958d872ba4
154 rdf:rest N47b32af854d143a297f7d6fe8a5b1f3a
155 N10f0e59c69444c92a9296dc06acd8836 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Proto-Oncogene Proteins B-raf
157 rdf:type schema:DefinedTerm
158 N18e2871013ef4da4a7bf85dc830dfacc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Gene Expression Regulation, Neoplastic
160 rdf:type schema:DefinedTerm
161 N18f67b73fab345d18588f479ecbd806a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 N20f359f588884b169dafcb958d872ba4 schema:affiliation grid-institutes:grid.411277.6
165 schema:familyName Lee
166 schema:givenName Jae Young
167 rdf:type schema:Person
168 N2403f3ad3b6443a8ab62f7ccfba75311 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Humans
170 rdf:type schema:DefinedTerm
171 N2a1e058b6b024bedab54aadf5d2e70fd rdf:first sg:person.016630576674.47
172 rdf:rest Nc89e171395cd42368483568cb7519565
173 N34221dfd1fd04e97bba432552583fad3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Survival Analysis
175 rdf:type schema:DefinedTerm
176 N37304afdd92b4379a72eaf0692885bb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Thyroid Neoplasms
178 rdf:type schema:DefinedTerm
179 N441f7c05f9b5425abfed28f0c548e689 rdf:first sg:person.0771453563.33
180 rdf:rest Nac75105943744443b54d1043f453f672
181 N471555c8f5424f1a85f236ec5d6c5042 schema:name doi
182 schema:value 10.1038/s41598-020-61828-z
183 rdf:type schema:PropertyValue
184 N47b32af854d143a297f7d6fe8a5b1f3a rdf:first sg:person.0703331164.54
185 rdf:rest N8ff6342b339840b09e4ff79782bbcb1d
186 N4984f15d372347318b20716186bbc9af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Thyroid Cancer, Papillary
188 rdf:type schema:DefinedTerm
189 N5e4f2f67bb01482eb81464128fe08e51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Down-Regulation
191 rdf:type schema:DefinedTerm
192 N6b6b2b842b224089a045b785e5d0fe13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Tumor Burden
194 rdf:type schema:DefinedTerm
195 N747f712158f148149ce7ad3d62de5a23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Case-Control Studies
197 rdf:type schema:DefinedTerm
198 N7e47cc8326ea445b9ee59b041e695bde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Cell Line, Tumor
200 rdf:type schema:DefinedTerm
201 N8b72477031714d01986a207a31464d7d schema:name Springer Nature - SN SciGraph project
202 rdf:type schema:Organization
203 N8c3abb0a99e24b918106f27f660eabb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Sex Characteristics
205 rdf:type schema:DefinedTerm
206 N8f04d35fec414fcd9e9948f221778804 schema:volumeNumber 10
207 rdf:type schema:PublicationVolume
208 N8ff6342b339840b09e4ff79782bbcb1d rdf:first sg:person.0701520567.75
209 rdf:rest N2a1e058b6b024bedab54aadf5d2e70fd
210 N93a27a53bd1d45ff911e38bdb07ebaaf schema:issueNumber 1
211 rdf:type schema:PublicationIssue
212 N959745a3a9e34459a2e5043398655a30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Prognosis
214 rdf:type schema:DefinedTerm
215 Nac75105943744443b54d1043f453f672 rdf:first sg:person.0651672565.45
216 rdf:rest N0515bae5a6e84b08a45c67a788087b11
217 Nb222fd60b1ba4139828f28ffac3cdcad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Neoplasm Staging
219 rdf:type schema:DefinedTerm
220 Nb5360373e96c4a44977076daab44cbf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name DNA Methylation
222 rdf:type schema:DefinedTerm
223 Nba2d66f3a9744bfb83470cedb7b9f539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Epigenesis, Genetic
225 rdf:type schema:DefinedTerm
226 Nbecc7f4311874fd5978a6188fb821f9f schema:name pubmed_id
227 schema:value 32184420
228 rdf:type schema:PropertyValue
229 Nc5aee7d7bade4d81909d0b391fc72c74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Calcium-Binding Proteins
231 rdf:type schema:DefinedTerm
232 Nc89e171395cd42368483568cb7519565 rdf:first sg:person.0640426775.09
233 rdf:rest rdf:nil
234 Nd4ff6e1251ac41eda43f000b179ceeeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
235 schema:name Male
236 rdf:type schema:DefinedTerm
237 Ndb88d75880904e849476f16c84345e41 schema:name dimensions_id
238 schema:value pub.1125689024
239 rdf:type schema:PropertyValue
240 Neb434e036ff04efe8cdd55703130dec6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
241 schema:name Amino Acid Substitution
242 rdf:type schema:DefinedTerm
243 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
244 schema:name Biological Sciences
245 rdf:type schema:DefinedTerm
246 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
247 schema:name Genetics
248 rdf:type schema:DefinedTerm
249 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
250 schema:name Medical and Health Sciences
251 rdf:type schema:DefinedTerm
252 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
253 schema:name Oncology and Carcinogenesis
254 rdf:type schema:DefinedTerm
255 sg:journal.1045337 schema:issn 2045-2322
256 schema:name Scientific Reports
257 schema:publisher Springer Nature
258 rdf:type schema:Periodical
259 sg:person.016630576674.47 schema:affiliation grid-institutes:grid.31501.36
260 schema:familyName Kim
261 schema:givenName Woo Ho
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016630576674.47
263 rdf:type schema:Person
264 sg:person.0640426775.09 schema:affiliation grid-institutes:grid.411277.6
265 schema:familyName Jang
266 schema:givenName Bo Gun
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640426775.09
268 rdf:type schema:Person
269 sg:person.0651672565.45 schema:affiliation grid-institutes:grid.411277.6
270 schema:familyName Choi
271 schema:givenName Jae Hyuck
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651672565.45
273 rdf:type schema:Person
274 sg:person.0701520567.75 schema:affiliation grid-institutes:grid.415464.6
275 schema:familyName Myung
276 schema:givenName Jae Kyung
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701520567.75
278 rdf:type schema:Person
279 sg:person.0703331164.54 schema:affiliation grid-institutes:grid.415464.6
280 schema:familyName Kang
281 schema:givenName JiHoon
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703331164.54
283 rdf:type schema:Person
284 sg:person.0771453563.33 schema:affiliation grid-institutes:grid.411277.6
285 schema:familyName Kim
286 schema:givenName Hye Sung
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771453563.33
288 rdf:type schema:Person
289 sg:pub.10.1007/s00401-011-0841-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1020149937
290 https://doi.org/10.1007/s00401-011-0841-z
291 rdf:type schema:CreativeWork
292 sg:pub.10.1007/s12020-013-9908-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1019492954
293 https://doi.org/10.1007/s12020-013-9908-z
294 rdf:type schema:CreativeWork
295 sg:pub.10.1038/nrendo.2011.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021894967
296 https://doi.org/10.1038/nrendo.2011.142
297 rdf:type schema:CreativeWork
298 sg:pub.10.1038/nrg3230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028633739
299 https://doi.org/10.1038/nrg3230
300 rdf:type schema:CreativeWork
301 sg:pub.10.1038/onc.2015.127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016735278
302 https://doi.org/10.1038/onc.2015.127
303 rdf:type schema:CreativeWork
304 grid-institutes:grid.31501.36 schema:alternateName Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea
305 schema:name Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea
306 rdf:type schema:Organization
307 grid-institutes:grid.411277.6 schema:alternateName Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea
308 Department of Surgery, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea
309 schema:name Department of Pathology, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea
310 Department of Surgery, Jeju National University School of Medicine and Jeju National University Hospital, Jeju, South Korea
311 rdf:type schema:Organization
312 grid-institutes:grid.415464.6 schema:alternateName Department of Pathology, Korea Cancer Center Hospital, Seoul, South Korea
313 Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, South Korea Institute of Radiological & Medical Sciences, Seoul, South Korea
314 schema:name Department of Pathology, Korea Cancer Center Hospital, Seoul, South Korea
315 Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, South Korea Institute of Radiological & Medical Sciences, Seoul, South Korea
316 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...